Source: International Congress 2018 – Functional genomics and COPD: new challenges
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Kobylyansky (Moscow, Russian Federation). To the molecular genetic mechanisms of the COPD pathogenesis. 935

Member's Comments

No comment yet.

Related content which might interest you: Are genetic defects of dienin a key link in the pathogenesis of COPD? Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Some pathogenetic mechanisms of inflammatory processes in smoking patients with COPD Source: Annual Congress 2007 - Smoking and the lung Year: 2007 Mechanisms of COPD exacerbations - molecular perspectives and pathophysiology Source: ERS Satellites 2021 Year: 2021 Genes, intervention and molecular mechanisms in COPD Source: Annual Congress 2007 - Physiological year in review Year: 2007 New phenotyping of corticosteroid-resistant asthma based on molecular mechanisms Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology Year: 2005 Unravelling the genetic basis of sarcoidosis Source: Eur Respir Monogr 2022; 96: 41-56 Year: 2022 Pathogenesis of lung cancer signalling pathways: roadmap for therapies Source: Eur Respir J 2009; 33: 1485-1497 Year: 2009 The consequences of novel insights into the pathophysiology of asthma for its treatment Source: Annual Congress 2008 - Should asthma no longer be considered an allergic disease? Year: 2008 Defective metabolic adaptation in the pathogenesis of COPD Source: International Congress 2019 – Metabolic alterations as a driver of chronicity in lung disease Year: 2019 The lung microbiome in obstructive airways disease: potential pathogenetic roles Source: Eur Respir Monogr 2019; 83: 140-157 Year: 2019 COPD – will new insights into molecular pathology define new therapies? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 The role of pathophysiological aspects and inflammatory markers in phenotyping COPD Source: Annual Congress 2010 - PG8 Postgraduate Course: Phenotypes of asthma and COPD Year: 2010 Omics in population studies: a molecular epidemiology perspective in chronic airway disease Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome Year: 2014 Cellular mechanisms underlying CCSP SNP association with chronic airway diseases Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Towards understanding the role of autoreactivity in COPD Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 To progress understanding of disease triggers and modifiers in sarcoidosis, stratification is the key Source: Eur Respir J, 50 (6) 1702002; 10.1183/13993003.02002-2017 Year: 2017